Sandra Valaitis
Gynecology · Chicago, ILNPI 1831125749
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $563 of the $909 with a category attached, or 61.9%. 6 manufacturers reported payments, led by C. R. Bard, Inc. & Subsidiaries at 38.1% of the total. Reporting peaked in 2021 at $347 and has fallen 60.7% since, to $136 in 2025.
Across 11 payments — averaging $82.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- C. R. Bard, Inc. & Subsidiaries$347
- Boston Scientific$312
- Intuitive Surgical$182
- Exeltis, USA Inc.$39
- Axonics, Inc.$16
- Baxter Healthcare$14
What the payments were for
- Consulting fees$34738%
- Food & beverage$56362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries | 1 | $347 |
| Boston Scientific | 4 | $312 |
| Intuitive Surgical | 2 | $182 |
| Exeltis, USA Inc. | 2 | $39 |
| Axonics, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Advantage System$161
- Solyx SIS System$113
How this compares
$909 in reported general payments places this provider in the 60th percentile of 68 gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 68 | $46,124 |
| Mirabegron ErMirabegron | 13 | $4,713 |
| Estradiol | 61 | $3,235 |
| Trospium Chloride | 40 | $1,549 |
| Tolterodine Tartrate ErTolterodine Tartrate | 32 | $1,520 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 98 | $1,215 |
| Oxybutynin Chloride | 31 | $511 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $199 |
| Solifenacin Succinate | 14 | $147 |
| Ibuprofen | 33 | $106 |
| Tramadol Hcl | 31 | $23 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Chicago
- Nicole WilliamsChicago$527K
- Lauren StreicherChicago$48K
- Monica MooreChicago$29K
- Catherine BrankinChicago$22K
- Obianuju Madueke-LaveauxChicago$15K
- Lisa OldhamChicago$6K
- Kayla Nixon MarshallChicago$4K
- Lisa LauChicago$2K
- Elliot LevineChicago$691
- Shari SnowChicago$520
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.